Roman Butler Fullerton & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
583
+91
| +18% | +$43.5K | 0.08% | 196 |
|
|
2025
Q1 | $217K | Buy |
492
+1
| +0.2% | +$441 | 0.08% | 205 |
|
|
2024
Q4 | $287K | Hold |
491
| – | – | 0.09% | 186 |
|
|
2024
Q3 | $295K | Buy |
491
+1
| +0.2% | +$601 | 0.09% | 195 |
|
|
2024
Q2 | $263K | Hold |
490
| – | – | 0.09% | 189 |
|
|
2024
Q1 | $269K | Sell |
490
-47
| -9% | -$25.8K | 0.1% | 177 |
|
|
2023
Q4 | $294K | Sell |
537
-115
| -18% | -$63K | 0.11% | 170 |
|
|
2023
Q3 | $315K | Buy |
652
+16
| +3% | +$7.72K | 0.15% | 146 |
|
|
2023
Q2 | $341K | Hold |
636
| – | – | 0.16% | 146 |
|
|
2023
Q1 | $349K | Hold |
636
| – | – | 0.17% | 147 |
|
|
2022
Q4 | $374K | Buy |
636
+4
| +0.6% | +$2.35K | 0.19% | 140 |
|
|
2022
Q3 | $318K | Buy |
632
+97
| +18% | +$48.8K | 0.2% | 133 |
|
|
2022
Q2 | $288K | Hold |
535
| – | – | 0.16% | 150 |
|
|
2022
Q1 | $316K | Hold |
535
| – | – | 0.15% | 154 |
|
|
2021
Q4 | $357K | Hold |
535
| – | – | 0.16% | 139 |
|
|
2021
Q3 | $314K | Buy |
535
+51
| +11% | +$29.9K | 0.15% | 152 |
|
|
2021
Q2 | $244K | Hold |
484
| – | – | 0.12% | 170 |
|
|
2021
Q1 | $239K | Sell |
484
-50
| -9% | -$24.7K | 0.12% | 175 |
|
|
2020
Q4 | $249K | Buy |
534
+51
| +11% | +$23.8K | 0.15% | 151 |
|
|
2020
Q3 | $213K | Buy |
+483
| New | +$213K | 0.14% | 150 |
|